Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 12/20 | 0.68 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10764009 | 0.80 | BRD4 (0.67) | BRD4ADRA1DADRA1AADRA1BSRD5A1 | |
| SCHEMBL2459716 | 0.78 | BRD4 (0.57) | BRD4ADRA1DADRA1AADRA1BSRD5A1 | |
| SCHEMBL6556310 | 0.75 | BRD4 (1.00) | BRD4SRD5A1PDE4APDE4BPDE4C | |
| SCHEMBL15203831 | 0.75 | BRD4 (1.00) | BRD4SRD5A1PDE4APDE4BPDE4C | |
| SCHEMBL8406210 | 0.75 | BRD4 (1.00) | BRD4SRD5A1PDE4APDE4BPDE4C | |
| SCHEMBL24877487 | 0.74 | ADRA1D (0.46) | ADRA1DADRA1AADRA1BMAOAMAOB | |
| SCHEMBL28288944 | 0.74 | BRD4 (0.49) | BRD4PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL11082926 | 0.73 | ADRA1A (0.40) | BRD4ADRA1DADRA1AADRA1BMAOA | |
| SCHEMBL10756940 | 0.72 | BRD4 (0.70) | BRD4SRD5A1PDE4APDE4BPDE4C | |
| SCHEMBL425265 | 0.72 | KDM1A (0.50) | ADRA1DADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6784167-B2 | TREATING OSTEOPOROSIS, OSTEOPENIA, OVARIAN CANCER, BREAST CANCER, ENDOMETRIAL CANCER, ENDOMETRIOSIS, PROSTATE CANCER, ACNE, ANDROGEN-DEPENDENT HAIR LOSS, NON-INSULIN-DEPENDENT DIABETES MELLITUS, OR HYPERCHOLESTEROLEMIA. | BAYER PHARMACEUTICALS CORPORATION | 2004-08-31 | — | — | US | claimed |